Pennsylvania Governor Josh Shapiro has made a move towards promoting fair competition in the state’s medical marijuana market. Last week, he signed SB 773 into law, with the aim of helping small and medium-sized businesses compete against major multistate operators (MSOs) dominating the industry.
For years, independent growers and retailers in Pennsylvania have faced significant challenges due to a restrictive state law that limits their ability to sell directly to patients. As a result, the market has been dominated by just a handful of MSOs, creating a near-monopoly situation.
However, with the signing of SB 773, this could all change. The new law allows independent medical cannabis cultivators and processors to apply for dispensary permits with up to three retail locations to sell directly to the state’s almost one million registered patients and caregivers. Additionally, independent retailers can now apply for grow permits and produce products for in-house sales.
This move not only promotes fair competition but also aims to protect against further industry consolidation. Under the new law, independent license holders cannot transfer their permits within one year of receiving an operational certificate. This provision helps prevent smaller players from being bought out by larger companies, thus maintaining a diverse marketplace.
Pennsylvania’s current state law on medical marijuana has been a major barrier for small and medium-sized businesses looking to enter the market. Under this law, independent growers and retailers are not allowed to sell directly to patients. Instead, they must go through one of the few licensed MSOs in the state.
Pennsylvania’s Medical Marijuana Act, enacted in 2016, currently specifies that no more than five of the state’s 25 grower/processor license holders be allowed to also hold dispensary permits and thus retail their product directly to medical marijuana patients.
This restriction has resulted in a near-monopoly situation where only a handful of companies control the entire market. This has had a significant impact on small and medium-sized businesses, as they struggle to compete with larger, well-established MSOs.
Furthermore, this monopoly prevents smaller players from being able to fully establish themselves in the market, hindering innovation and diversity within the industry. The limited number of players also makes it difficult for patients to have a variety of options when it comes to their medical marijuana needs.
SB 773
SB 773 is a bill that aims to address the current limitations faced by independent growers and retailers in Pennsylvania’s medical marijuana market. The law allows for the ten independent cultivators and processors in the state to apply for dispensary permits with up to three retail locations, giving them the opportunity to sell directly to patients. While allowing the state’s four independent dispensaries to to apply for growing permits to cultivate and have in-house products in their dispensaries.
This replaces the current law that states no more than five of the state’s 25 grower-processor license holders can also hold dispensary licenses. Others must sell their products to a licensed dispensary, which in turn can sell products to patients according to Marijuana Moment.
In addition to promoting fair competition by leveling the playing field for independent growers and retailers, SB 773 also aims to prevent further industry consolidation. The provision that prohibits independent license holders from transferring their permits within one year of receiving an operational certificate helps keep smaller players in the market and maintains diversity within the industry.
However, this new law may face some challenges and pushback from major MSOs. These companies may oppose allowing independent businesses to have more control over their operations and sales, as it could potentially impact their profits. Additionally, there may be concerns about ensuring safety and quality standards for medical marijuana products produced by independent growers.
Major multistate operators that currently hold licenses in Pennsylvania include Cresco Labs, Curaleaf Holdings, Jushi Holdings, Green Thumb Industries, PharmaCann, TerrAscend and Trulieve Cannabis according to MJBizDaily.
Financial Impact
The expansion of medical marijuana licenses for independent operators in Pennsylvania has the potential to generate significant revenue for both the state and the industry. With ten independent cultivators and processors now able to sell directly to patients, there will likely be an increase in sales and profits. Additionally, the four independent dispensaries that are now permitted to cultivate and have in-house products may also see a rise in revenue.
This increase in revenue not only benefits the businesses involved but also has a positive impact on the state’s economy. More sales mean more tax revenue for Pennsylvania, which can be used towards various programs and initiatives. It also helps support the growth of the medical marijuana industry as a whole, providing more opportunities for businesses to thrive and expand.
Last month estimates that the passing of SB 773 would bring in close to $2 million in revenue from application and permit fees. Also, the state could expect to generate about $90,000 annually.
Moreover, the expansion of medical marijuana licenses could also lead to job creation. As independent operators grow their businesses and increase production, there will be a need for more employees to meet the demand. This opens up potential job opportunities in cultivation, processing, retail sales, and other related fields within the industry.
Future of Cannabis Policy in Pennsylvania
The passing of SB 773 is a significant step towards leveling the playing field for independent operators in Pennsylvania’s medical marijuana market. However, with 5 neighboring states legalizing adult-use cannabis, many are wondering if Pennsylvania will follow suit.
Senator John Fetterman, who has been an advocate for cannabis reform in the state, believes that it is only a matter of time before Pennsylvania legalizes adult-use marijuana.
“Four or five years ago, everyone thought I was weird or just a stoner because I believed that [cannabis law reform] was the right way to go,” said Fetterman in a Q&A with City and State PA. “Republicans at the time said, ‘We don’t want this, and the majority of people don’t either.’ We found out we actually do, and now we have been lapped by New York, New Jersey, Maryland, D.C., and now Ohio.”
If adult-use legalization were to occur in Pennsylvania, it could have significant implications for the medical marijuana industry. It is possible that some patients may choose to purchase their cannabis from recreational dispensaries instead of continuing to use medical dispensaries. However, this could also create a larger market for all cannabis businesses in the state, potentially driving up demand and revenue.
SB 773 is a significant step towards promoting fair competition and preventing industry consolidation in Pennsylvania’s medical marijuana market. This new law allows independent operators to have more control over their operations and sales, potentially leading to an increase in revenue for both the businesses and the state.
However, with neighboring states legalizing adult-use cannabis, it is possible that Pennsylvania may follow suit in the future. This could have implications for the medical marijuana market, but also presents potential growth opportunities for all cannabis businesses in the state.
This expansion of access to medical marijuana licenses showcases progress towards more inclusive cannabis policies in Pennsylvania and sets the stage for further developments in the industry. So, it is an exciting time to be involved in the medical marijuana industry in Pennsylvania, and we look forward to seeing how these changes will continue to shape its future.
Keep updated on all the latest news and updates in the Cannabis industry here at Beard Bros Pharms by signing up for our Friday Sesh Newsletter here. Always Dank and Never Spam!
